Rheumatoid Arthritis Clinical Trials in San Antonio

Showing 1361-1380 of 2,746 trials

Quetiapine Augmentation of PE Therapy for the Treatment of Co-occurring PTSD and Mild Traumatic Brain Injury

NCT04280965

A pilot study to evaluate feasibility for a full-scale merit application. Specifically, for veterans considering prolonged exposure (PE) therapy, following the model established by Foa et al, we need to establish safety, and feasibility of quetiapine compared to treatment as usual (TAU) which employs multiple medications commonly used for PTSD in the VA system.

Post Traumatic Stress Disorder

The University of Texas Health Science Center at San Antonio28 participantsStarted Feb 2019

San Antonio, Texas, United States

COMPLETEDPhase 2< 1 mile

Evaluate the Efficacy and Safety of ACP-044 for the Treatment of Acute Postoperative Pain Following Bunionectomy

NCT04855240

To evaluate the efficacy of ACP-044 compared with placebo in the treatment of acute postoperative pain

Acute Postoperative PainBunionectomy

ACADIA Pharmaceuticals Inc.239 participantsStarted Mar 2021

Anaheim, California, United States • Pasadena, Maryland, United States • San Antonio, Texas, United States +1 more locations

COMPLETEDPhase 2< 1 mile

Efficacy and Safety of NYX-2925 in Subjects With Neuropathic Pain Associated With Diabetic Peripheral Neuropathy (DPN)

NCT04146896

To evaluate the efficacy of NYX-2925 versus placebo in treating the neuropathic pain associated with diabetic peripheral neuropathy.

Diabetic Peripheral Neuropathic Pain

Aptinyx228 participantsStarted Nov 2019

Fresno, California, United States • Irvine, California, United States • Lomita, California, United States +32 more locations

Quetiapine Augmentation of PE Therapy for the Treatment of Co-occurring PTSD and Mild Traumatic Brain Injury

Evaluate the Efficacy and Safety of ACP-044 for the Treatment of Acute Postoperative Pain Following Bunionectomy

Efficacy and Safety of NYX-2925 in Subjects With Neuropathic Pain Associated With Diabetic Peripheral Neuropathy (DPN)

Rheumatoid Arthritis Trials in Other Cities

FX-322 in Adults With Stable Sensorineural Hearing Loss

First in Human Safety Study of FX-345 in Adults With Sensorineural Hearing Loss

Safety, Tolerability, and Pharmacokinetics of CAL056 Mesylate in Patients With Resistant or Refractory Solid Tumors

Randomized Trial in Adult Participants With Acute Migraines

A Safety and Efficacy Study of XERMELO® + First-line Chemotherapy in Patients With Advanced Biliary Tract Cancer

Multi-Center Trial Utilizing Low Frequency Ultrasound in the Prevention of Post-Contrast Acute Kidney Injury

Comparing NUC-1031 Plus Cisplatin to Gemcitabine Plus Cisplatin in Patients With Advanced Biliary Tract Cancer

A Study of TAK-951 to Stop Adults Getting Nausea and Vomiting After Planned Surgery

MK-7625A Versus Meropenem in Pediatric Participants With Complicated Urinary Tract Infection (cUTI) (MK-7625A-034)

Safety and Efficacy of Abaloparatide-SC in Men With Osteoporosis (ATOM)

rhBMP-2/CRM/CD HORIZON® Spinal System Pivotal Study

Relative Bioavailability of LY03010 Compared to Listed Drug

Study Evaluating ABT-199 in Participants With Relapsed or Refractory Multiple Myeloma

MK-7625A Plus Metronidazole Versus Meropenem in Pediatric Participants With Complicated Intra-Abdominal Infection (cIAI) (MK-7625A-035)

DPX-Survivac and Pembrolizumab With and Without Intermittent Low-Dose Cyclophosphamide, in Subjects With Relapsed/Refractory Diffuse Large B-Cell Lymphoma

First-In-Human Study To Evaluate Safety, Tolerability, And Pharmacokinetics Following Single Ascending And Multiple Ascending Doses of PF-07304814 In Hospitalized Participants With COVID-19.

Momelotinib Versus Ruxolitinib in Subjects With Myelofibrosis

Other Conditions in San Antonio